[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Urabe A, Fujita A, Aoki K, Koike M, Kitamura K, Ohbayashi Y, Oshimi K, Wakabayashi Y, Kuraishi Y, Kurihara I, Togawa A, Hoshino S, Ozawa K, Hotta T, Higashihara M, Nagoshi H, Hirai H, Omine M, Asano S, Nishimura M, Suzuki K, Bessho M, Mizoguchi H, Furusawa S, Nonaka Y, Takaku F.
Urabe A, et al. Among authors: kitamura k.
Jpn J Antibiot. 2000 Feb;53(2):61-74.
Jpn J Antibiot. 2000.
PMID: 10786314
Clinical Trial.
Japanese.